Global (United States, European Union and China) Combined hormonal contraceptive Market Research Report 2019-2025

Publisher Name :
Date: 16-Aug-2019
No. of pages: 118
Inquire Before Buying

Combined hormonal contraceptive basically made by a combination of an estrogen and a progestogen which are primarily used to prevent unwanted pregnancies. Combined hormonal contraceptives are one of the effective contraceptives in modern medicine. Since late 1950s variety of innovation has been developed to improve the efficacy and safety of combined hormonal contraceptive. The trends have been shifted towards less androgenic progestogens and lower doses of estrogen and progestogen. Changing in drug doses and modification in drug component with the incorporation of new technologies that can reduce the risk factor and the continuing development of novel delivery systems that can be helpful to fulfill unmet needs of the market. The other health benefits of combined hormonal contraceptives include they reduce the risk of iron deficiency anemia, endometriosis, used in treating acne vulgaris, irregular menstrual flow, and polycystic ovarian syndrome. The mechanism of combined hormonal contraceptive is inhibition of follicle stimulating hormone and luteinizing hormone. Ethinylestradiol is the most common estrogen used in combined hormonal contraceptives, whereas other hormones are also used. The combined hormonal contraceptive products are available in various forms whereas pills have the maximum share in the combined hormonal contraceptive market. According to the Association of Women Health, around 100 million women use combined hormonal contraceptives throughout the world.

The growth of the combined hormonal contraceptive market is driven by growing predominance and more productive medications with emerging interest in quick substitutes. Reduction in the cost of hospitalization and high efficacy can be the prime driving factors for the growth of the combined hormonal contraceptive market over the forecast period. In emerging countries, the adoption of combined hormonal contraceptives has increased, along with increasing health consciousness and awareness. Growing menstruating population worldwide and various initiatives taken by the governments, such as birth control and women health awareness programs, are factors expected to increase the usage of combined hormonal contraceptive products globally. Strategic collaborations and acquisitions among manufacturers are also expected to boost the growth of the combined hormonal contraceptive market. However, side effects related to the combined hormonal contraceptive products can hamper the growth of the combined hormonal contraceptive market.

In 2019, the market size of Combined hormonal contraceptive is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Combined hormonal contraceptive.

This report studies the global market size of Combined hormonal contraceptive, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Combined hormonal contraceptive sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Teva Pharmaceutical Industries

- Bayer HealthCare Pharmaceuticals

- Actavis

- Pfizer

- Johnson & Johnson

- GlaxoSmithKline

- Watson Pharma

- Cipla

- Novartis International

Market Segment by Product Type

- Pills

- Patch

- Ring

Market Segment by Application

- Hospital Pharmacies

- Retail Pharmacies

- E-commerce

- Others

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Combined hormonal contraceptive status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Combined hormonal contraceptive manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Combined hormonal contraceptive are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Combined hormonal contraceptive Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Combined hormonal contraceptive Market Size Growth Rate by Type (2019-2025)
1.3.2 Pills
1.3.3 Patch
1.3.4 Ring
1.4 Market Segment by Application
1.4.1 Global Combined hormonal contraceptive Market Share by Application (2019-2025)
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 E-commerce
1.4.5 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Combined hormonal contraceptive Market Size
2.1.1 Global Combined hormonal contraceptive Revenue 2014-2025
2.1.2 Global Combined hormonal contraceptive Sales 2014-2025
2.2 Combined hormonal contraceptive Growth Rate by Regions
2.2.1 Global Combined hormonal contraceptive Sales by Regions 2014-2019
2.2.2 Global Combined hormonal contraceptive Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Combined hormonal contraceptive Sales by Manufacturers
3.1.1 Combined hormonal contraceptive Sales by Manufacturers 2014-2019
3.1.2 Combined hormonal contraceptive Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Combined hormonal contraceptive Revenue by Manufacturers (2014-2019)
3.2.2 Combined hormonal contraceptive Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Combined hormonal contraceptive Market Concentration Ratio (CR5 and HHI)
3.3 Combined hormonal contraceptive Price by Manufacturers
3.4 Key Manufacturers Combined hormonal contraceptive Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Combined hormonal contraceptive Market
3.6 Key Manufacturers Combined hormonal contraceptive Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Pills Sales and Revenue (2014-2019)
4.1.2 Patch Sales and Revenue (2014-2019)
4.1.3 Ring Sales and Revenue (2014-2019)
4.2 Global Combined hormonal contraceptive Sales Market Share by Type
4.3 Global Combined hormonal contraceptive Revenue Market Share by Type
4.4 Combined hormonal contraceptive Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Combined hormonal contraceptive Sales by Application
6 United States
6.1 United States Combined hormonal contraceptive Breakdown Data by Company
6.2 United States Combined hormonal contraceptive Breakdown Data by Type
6.3 United States Combined hormonal contraceptive Breakdown Data by Application
7 European Union
7.1 European Union Combined hormonal contraceptive Breakdown Data by Company
7.2 European Union Combined hormonal contraceptive Breakdown Data by Type
7.3 European Union Combined hormonal contraceptive Breakdown Data by Application
8 China
8.1 China Combined hormonal contraceptive Breakdown Data by Company
8.2 China Combined hormonal contraceptive Breakdown Data by Type
8.3 China Combined hormonal contraceptive Breakdown Data by Application
9 Rest of World
9.1 Rest of World Combined hormonal contraceptive Breakdown Data by Company
9.2 Rest of World Combined hormonal contraceptive Breakdown Data by Type
9.3 Rest of World Combined hormonal contraceptive Breakdown Data by Application
9.4 Rest of World Combined hormonal contraceptive Breakdown Data by Countries
9.4.1 Rest of World Combined hormonal contraceptive Sales by Countries
9.4.2 Rest of World Combined hormonal contraceptive Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Teva Pharmaceutical Industries
10.1.1 Teva Pharmaceutical Industries Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
10.1.4 Combined hormonal contraceptive Product Introduction
10.1.5 Teva Pharmaceutical Industries Recent Development
10.2 Bayer HealthCare Pharmaceuticals
10.2.1 Bayer HealthCare Pharmaceuticals Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
10.2.4 Combined hormonal contraceptive Product Introduction
10.2.5 Bayer HealthCare Pharmaceuticals Recent Development
10.3 Actavis
10.3.1 Actavis Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
10.3.4 Combined hormonal contraceptive Product Introduction
10.3.5 Actavis Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
10.4.4 Combined hormonal contraceptive Product Introduction
10.4.5 Pfizer Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
10.5.4 Combined hormonal contraceptive Product Introduction
10.5.5 Johnson & Johnson Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
10.6.4 Combined hormonal contraceptive Product Introduction
10.6.5 GlaxoSmithKline Recent Development
10.7 Watson Pharma
10.7.1 Watson Pharma Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
10.7.4 Combined hormonal contraceptive Product Introduction
10.7.5 Watson Pharma Recent Development
10.8 Cipla
10.8.1 Cipla Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
10.8.4 Combined hormonal contraceptive Product Introduction
10.8.5 Cipla Recent Development
10.9 Novartis International
10.9.1 Novartis International Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Combined hormonal contraceptive
10.9.4 Combined hormonal contraceptive Product Introduction
10.9.5 Novartis International Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Combined hormonal contraceptive Sales Channels
11.2.2 Combined hormonal contraceptive Distributors
11.3 Combined hormonal contraceptive Customers
12 Market Forecast
12.1 Global Combined hormonal contraceptive Sales and Revenue Forecast 2019-2025
12.2 Global Combined hormonal contraceptive Sales Forecast by Type
12.3 Global Combined hormonal contraceptive Sales Forecast by Application
12.4 Combined hormonal contraceptive Forecast by Regions
12.4.1 Global Combined hormonal contraceptive Sales Forecast by Regions 2019-2025
12.4.2 Global Combined hormonal contraceptive Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Combined hormonal contraceptive Product Picture
Table Combined hormonal contraceptive Key Market Segments
Table Major Manufacturers Combined hormonal contraceptive Covered in This Report
Table Global Combined hormonal contraceptive Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
Figure Global Combined hormonal contraceptive Sales Market Shar by Type 2014-2025
Figure Pills Figures
Table Major Manufacturers of Pills
Figure Patch Figures
Table Major Manufacturers of Patch
Figure Ring Figures
Table Major Manufacturers of Ring
Table Global Combined hormonal contraceptive Market Share by Application 2019-2025 (K MT)
Figure Hospital Pharmacies Use Case
Figure Retail Pharmacies Use Case
Figure E-commerce Use Case
Figure Others Use Case
Figure Combined hormonal contraceptive Report Years Considered
Figure Global Combined hormonal contraceptive Market Size 2014-2025 (Million US$)
Figure Global Combined hormonal contraceptive Sales 2014-2019 (K MT)
Table Global Combined hormonal contraceptive Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Combined hormonal contraceptive Sales by Regions 2014-2019 (K MT)
Table Global Combined hormonal contraceptive Sales Market Share by Regions 2014-2019
Figure Global Combined hormonal contraceptive Sales Market Share by Regions 2014-2019
Figure Global Combined hormonal contraceptive Sales Market Share by Regions in 2019
Table Global Combined hormonal contraceptive Revenue by Regions 2014-2019 (Million US$)
Table Global Combined hormonal contraceptive Revenue Market Share by Regions 2014-2019
Figure Global Combined hormonal contraceptive Revenue Market Share by Regions 2014-2019
Figure Global Combined hormonal contraceptive Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Combined hormonal contraceptive Sales by Manufacturers (2014-2019) (K MT)
Table Global Combined hormonal contraceptive Sales Share by Manufacturers (2014-2019)
Figure Global Combined hormonal contraceptive Sales Share by Manufacturers in 2019
Table Combined hormonal contraceptive Revenue by Manufacturers (2014-2019) (Million USD)
Table Combined hormonal contraceptive Revenue Share by Manufacturers (2014-2019)
Figure Combined hormonal contraceptive Value Share by Manufacturers in 2019
Table Global Combined hormonal contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Combined hormonal contraceptive Price (2014-2019) (USD/MT)
Table Key Manufacturers Combined hormonal contraceptive Plants/Factories Distribution
Table Key Manufacturers Combined hormonal contraceptive Area Served
Table Date of Key Manufacturers Enter into Combined hormonal contraceptive Market
Table Key Manufacturers Combined hormonal contraceptive Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Pills Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Patch Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Ring Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Combined hormonal contraceptive Sales by Type (2014-2019) (K MT)
Table Global Combined hormonal contraceptive Sales Share by Type (2014-2019)
Figure Global Combined hormonal contraceptive Sales Market Share by Type (2014-2019)
Figure Global Combined hormonal contraceptive Sales Market Share by Type in 2018
Table Global Combined hormonal contraceptive Revenue by Type (2014-2019) (Million US$)
Table Global Combined hormonal contraceptive Revenue Share by Type (2014-2019)
Figure Global Combined hormonal contraceptive Revenue Market Share by Type (2014-2019)
Figure Global Combined hormonal contraceptive Revenue Market Share by Type in 2018
Table Combined hormonal contraceptive Price by Type 2014-2019 (USD/MT)
Table Global Combined hormonal contraceptive Sales by Application (2014-2019) (K MT)
Table Global Combined hormonal contraceptive Sales Share by Application (2014-2019)
Figure Global Sales Combined hormonal contraceptive Market Share by Application (2014-2019)
Figure Global Sales Combined hormonal contraceptive Market Share by Application (2014-2019)
Figure United States Combined hormonal contraceptive Sales Growth Rate 2014-2019 (K MT)
Figure United States Combined hormonal contraceptive Revenue Growth Rate 2014-2019 (Million US$)
Table United States Combined hormonal contraceptive Sales by Company (2014-2019) (K MT)
Table United States Combined hormonal contraceptive Sales Market Share by Company (2014-2019)
Figure United States Combined hormonal contraceptive Sales Market Share by Company in 2019
Table United States Combined hormonal contraceptive Sales by Type (2014-2019) (K MT)
Table United States Combined hormonal contraceptive Sales Market Share by Type (2014-2019)
Figure United States Combined hormonal contraceptive Market Share by Type in 2019
Table United States Combined hormonal contraceptive Sales by Application (2014-2019) (K MT)
Table United States Combined hormonal contraceptive Sales Market Share by Application (2014-2019)
Figure United States Combined hormonal contraceptive Market Share by Application in 2019
Figure European Union Combined hormonal contraceptive Sales Growth Rate 2014-2019 (K MT)
Figure European Union Combined hormonal contraceptive Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Combined hormonal contraceptive Sales by Company (2014-2019) (K MT)
Table European Union Combined hormonal contraceptive Sales Market Share by Company (2014-2019)
Figure European Union Combined hormonal contraceptive Sales Market Share by Company in 2019
Table European Union Combined hormonal contraceptive Sales by Type (2014-2019) (K MT)
Table European Union Combined hormonal contraceptive Sales Market Share by Type (2014-2019)
Figure 2018 European Union Combined hormonal contraceptive Market Share by Type
Table European Union Combined hormonal contraceptive Sales by Application (2014-2019) (K MT)
Table European Union Combined hormonal contraceptive Sales Market Share by Application (2014-2019)
Figure 2018 European Union Combined hormonal contraceptive Market Share by Application
Figure China Combined hormonal contraceptive Sales Growth Rate 2014-2019 (K MT)
Figure China Combined hormonal contraceptive Revenue Growth Rate 2014-2019 (Million US$)
Table China Combined hormonal contraceptive Sales by Company (2014-2019) (K MT)
Table China Combined hormonal contraceptive Sales Market Share by Company (2014-2019)
Figure China Combined hormonal contraceptive Sales Market Share by Company in 2019
Table China Combined hormonal contraceptive Sales by Type (2014-2019) (K MT)
Table China Combined hormonal contraceptive Sales Market Share by Type (2014-2019)
Figure China Combined hormonal contraceptive Market Share by Type in 2019
Table China Combined hormonal contraceptive Sales by Application (2014-2019) (K MT)
Table China Combined hormonal contraceptive Sales Market Share by Application (2014-2019)
Figure China Combined hormonal contraceptive Market Share by Application in 2019
Figure Rest of World Combined hormonal contraceptive Sales Growth Rate 2014-2019 (K MT)
Figure Rest of World Combined hormonal contraceptive Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Combined hormonal contraceptive Sales by Company (2014-2019) (K MT)
Table Rest of World Combined hormonal contraceptive Sales Market Share by Company (2014-2019)
Figure Rest of World Combined hormonal contraceptive Sales Market Share by Company in 2019
Table Rest of World Combined hormonal contraceptive Sales by Type (2014-2019) (K MT)
Table Rest of World Combined hormonal contraceptive Sales Market Share by Type (2014-2019)
Figure Rest of World Combined hormonal contraceptive Market Share by Type in 2019
Table Rest of World Combined hormonal contraceptive Sales by Application (2014-2019) (K MT)
Table Rest of World Combined hormonal contraceptive Sales Market Share by Application (2014-2019)
Figure Rest of World Combined hormonal contraceptive Market Share by Application in 2019
Table Rest of World Combined hormonal contraceptive Sales by Countries (2014-2019) (K MT)
Table Rest of World Combined hormonal contraceptive Sales Market Share by Countries (2014-2019)
Figure Rest of World Combined hormonal contraceptive Sales Market Share by Countries in 2019
Table Rest of World Combined hormonal contraceptive Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Combined hormonal contraceptive Revenue Market Share by Countries (2014-2019)
Figure Rest of World Combined hormonal contraceptive Revenue Market Share by Countries in 2019
Figure Japan Combined hormonal contraceptive Sales Growth Rate (2014-2019) (K MT)
Figure Japan Combined hormonal contraceptive Revenue Growth Rate (2014-2019) (K MT)
Figure Korea Combined hormonal contraceptive Sales Growth Rate (2014-2019) (K MT)
Figure Korea Combined hormonal contraceptive Revenue Growth Rate (2014-2019) (K MT)
Figure India Combined hormonal contraceptive Sales Growth Rate (2014-2019) (K MT)
Figure India Combined hormonal contraceptive Revenue Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Combined hormonal contraceptive Sales Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Combined hormonal contraceptive Revenue Growth Rate (2014-2019) (K MT)
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Description and Business Overview
Table Teva Pharmaceutical Industries Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Combined hormonal contraceptive Sales Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Combined hormonal contraceptive Sales Market Share in Global Market
Table Teva Pharmaceutical Industries Recent Development
Table Bayer HealthCare Pharmaceuticals Company Details
Table Bayer HealthCare Pharmaceuticals Description and Business Overview
Table Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Sales Growth Rate (2014-2019)
Table Bayer HealthCare Pharmaceuticals Combined hormonal contraceptive Sales Market Share in Global Market
Table Bayer HealthCare Pharmaceuticals Recent Development
Table Actavis Company Details
Table Actavis Description and Business Overview
Table Actavis Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Actavis Combined hormonal contraceptive Sales Growth Rate (2014-2019)
Table Actavis Combined hormonal contraceptive Sales Market Share in Global Market
Table Actavis Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Combined hormonal contraceptive Sales Growth Rate (2014-2019)
Table Pfizer Combined hormonal contraceptive Sales Market Share in Global Market
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Description and Business Overview
Table Johnson & Johnson Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Johnson & Johnson Combined hormonal contraceptive Sales Growth Rate (2014-2019)
Table Johnson & Johnson Combined hormonal contraceptive Sales Market Share in Global Market
Table Johnson & Johnson Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Description and Business Overview
Table GlaxoSmithKline Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline Combined hormonal contraceptive Sales Growth Rate (2014-2019)
Table GlaxoSmithKline Combined hormonal contraceptive Sales Market Share in Global Market
Table GlaxoSmithKline Recent Development
Table Watson Pharma Company Details
Table Watson Pharma Description and Business Overview
Table Watson Pharma Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Watson Pharma Combined hormonal contraceptive Sales Growth Rate (2014-2019)
Table Watson Pharma Combined hormonal contraceptive Sales Market Share in Global Market
Table Watson Pharma Recent Development
Table Cipla Company Details
Table Cipla Description and Business Overview
Table Cipla Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Cipla Combined hormonal contraceptive Sales Growth Rate (2014-2019)
Table Cipla Combined hormonal contraceptive Sales Market Share in Global Market
Table Cipla Recent Development
Table Novartis International Company Details
Table Novartis International Description and Business Overview
Table Novartis International Combined hormonal contraceptive Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis International Combined hormonal contraceptive Sales Growth Rate (2014-2019)
Table Novartis International Combined hormonal contraceptive Sales Market Share in Global Market
Table Novartis International Recent Development
Figure Combined hormonal contraceptive Value Chain
Table Combined hormonal contraceptive Distributors List
Table Combined hormonal contraceptive Customers List
Table Global Combined hormonal contraceptive Sales Forecast 2019-2025 (K MT) & (Million US$)
Figure Global Combined hormonal contraceptive Sales Forecast 2019-2025 (K MT)
Figure Global Combined hormonal contraceptive Revenue Forecast 2019-2025 (Million US$)
Table Global Combined hormonal contraceptive Sales Forecast by Type 2019-2025 (K MT)
Figure Global Combined hormonal contraceptive Sales Forecast by Type 2019-2025 (K MT)
Figure Global Combined hormonal contraceptive Sales Market Share Forecast by Type 2019-2025
Table Global Combined hormonal contraceptive Sales Forecast by Application 2019-2025 (K MT)
Figure Global Combined hormonal contraceptive Sales Forecast by Application 2019-2025 (K MT)
Figure Global Combined hormonal contraceptive Sales Market Share Forecast by Application 2019-2025
Table Global Combined hormonal contraceptive Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Combined hormonal contraceptive Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Combined hormonal contraceptive Sales Market Share Forecast by Regions 2019-2025
Table Global Combined hormonal contraceptive Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Combined hormonal contraceptive Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Combined hormonal contraceptive Revenue Market Share Forecast by Regions 2019-2025
Figure United States Combined hormonal contraceptive Sales Forecast 2019-2025 (K MT)
Figure United States Combined hormonal contraceptive Revenue Forecast 2019-2025 (Million US$)
Figure European Union Combined hormonal contraceptive Sales Forecast 2019-2025 (K MT)
Figure European Union Combined hormonal contraceptive Revenue Forecast 2019-2025 (Million US$)
Figure China Combined hormonal contraceptive Sales Forecast 2019-2025 (K MT)
Figure China Combined hormonal contraceptive Revenue Forecast 2019-2025 (Million US$)
Figure Japan Combined hormonal contraceptive Sales Forecast 2019-2025 (K MT)
Figure Japan Combined hormonal contraceptive Revenue Forecast 2019-2025 (Million US$)
Figure Korea Combined hormonal contraceptive Sales Forecast 2019-2025 (K MT)
Figure Korea Combined hormonal contraceptive Revenue Forecast 2019-2025 (Million US$)
Figure India Combined hormonal contraceptive Sales Forecast 2019-2025 (K MT)
Figure India Combined hormonal contraceptive Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Combined hormonal contraceptive Sales Forecast 2019-2025 (K MT)
Figure Southeast Asia Combined hormonal contraceptive Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Topical Pain Killers Market Professional Survey Report 2019
    Published: 16-Sep-2019        Price: US 3500 Onwards        Pages: 112
    Topical pain killers are rubbed into the skin to over painful muscles or joints. The global Topical Pain Killers market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Topical Pain Killers volume and value at global level, regional level and company level. From a global perspective, this report represents overall Topical Pain Killers market size by analyzing historical d......
  • Global Over the Counter (OTC) Drugs & Dietary Supplements Market Professional Survey Report 2019
    Published: 16-Sep-2019        Price: US 3500 Onwards        Pages: 112
    Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements. The global Over the ......
  • Global Antidiarrheal Drugs Market Professional Survey Report 2019
    Published: 16-Sep-2019        Price: US 3500 Onwards        Pages: 112
    Antidiarrheal drugs are used to treat abrupt diarrhea and possess the mechanism of slowing down the movement of the gut and helps to diminish the number of bowel movements and also make the stools less watery. Distinct causes of diarrhea can be a virus such as a rotavirus, hepatitis, a bacterium such as E.coli, Shigella, and parasites causing amoebiasis and giardiasis. Majority of the events of diarrhea are recognized to be concluded with simple dietary modifications and may not require treatmen......
  • Global Macrolide Drugs Market Professional Survey Report 2019
    Published: 16-Sep-2019        Price: US 3500 Onwards        Pages: 112
    The macrolide drugs are a group of antibiotics produced by various strains of Streptomyces (spore forming bacteria that grow slowly in soil or water as a branching filamentous mycelium similar to that of fungi) and have a complex chemical (macrocyclic) structure. They act by inhibiting protein synthesis, specifically by blocking the 50S ribosomal subunit. They are broad spectrum antibiotics. The global Macrolide Drugs market was valued at xx million US$ in 2018 and will reach xx m......
  • Global Chronic Obstructive Pulmonary Disease Drugs Market Professional Survey Report 2019
    Published: 16-Sep-2019        Price: US 3500 Onwards        Pages: 112
    Chronic obstructive pulmonary disease ( COPD ) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. The inhalers segment dominated the global COPD drugs market The global Chronic Obstructive Pulmonary Disease Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Chronic Obstructive Pulmonary Disease Drugs volume and value a......
  • Global Drugs for Central Nervous System Market Professional Survey Report 2019
    Published: 16-Sep-2019        Price: US 3500 Onwards        Pages: 112
    The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. In this report, we study the drugs for central nervous system disease. The global Drugs for Central Nervous System market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Drugs for Central Nervous System volume and value at global level, regional level and company le......
  • Global Endometriosis Market Professional Survey Report 2019
    Published: 16-Sep-2019        Price: US 3500 Onwards        Pages: 112
    Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor. Rising incidences of endometriosis due to diagnostic improvements leading to early identification, environmental factors, and rising awareness is the key factor contributing to growth of the market. Global endometriosis market is expected to register a healthy growth, owing to rise in awareness am......
  • Global Gaucher Disease Treatment Market Professional Survey Report 2019
    Published: 16-Sep-2019        Price: US 3500 Onwards        Pages: 112
    The global Gaucher Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gaucher Disease Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gaucher Disease Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production,......
  • Global Pharmaceutical Grade Gelatin Market Professional Survey Report 2019
    Published: 16-Sep-2019        Price: US 3500 Onwards        Pages: 112
    Pharmaceutical grade gelatin is colorless, water soluble, translucent, and a delicate element that has a high molecular weight. It is derived from skin, white connective tissues, and bones of animals by partial hydrolysis of collagen. Gelatin is harmless and absorbable, which is why it is employed in various pharmaceutical applications. It is used as a suspending agent (assists in maintaining the stability of pharmaceutical suspensions) and in manufacturing capsules. In addition, gelatin serves ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs